Sign in
4

Changes in Ownership

Keros Therapeutics, Inc. Filed Acc 0002081460-26-000009

Chief Legal Officer sold 4,485 shares at $10.29 ($46,151)

From the SEC's structured data for this filing

Trades in this filing

Cho Esther · Chief Legal Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-08-18 Sale : show line 1 in the form −4,485 $10.29 $46,151 35,770 D
Open-market sales · 4,485 sh · avg $10.29 · $46,151
Loading xslF345X06/form4-08202026_040803.xml…